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 = aryl or alkyl) in moderate to excellent yield (57 
- 90%). The latter react with 2,4-bis(phenyl)-1,3-diselenadiphosphetane-2,4-diselenide (Woollins’ reagent, WR) 
in refluxing toluene to give a series of new 2,5-disubstituted-1,3,4-selenadiazoles (2a-t, 51-99% yield). All 
compounds were characterized spectroscopically and six compounds were characterized crystallographically. 
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Introduction 
    The synthesis of an organoselenium compound, diethyl selenide, was first reported in 1836.
[1]
 It was 
not until the 1970s, where the use of diethyl selenide in several new reactions created a variety of novel 
structures with unusual properties, that these compounds began to attract more general interest. The 
interest in using organoselenium heterocycles as potential pharmaceuticals and new materials,  as well as 
reagents and catalysts expanded rapidly during last three decades.
[2]
 For example, 1,3,4-selenadiazoles 
have been studied because of their potential activities as anti-bacterial, analgesic, anti-tumor, anti-
convulsant, and anti-inflammatory drugs, pesticides and fungicides.
[3]
 Furthermore, some of them have 
been used as thermotropic liquid crystals, corrosion and oxidation inhibitors, or as dyes or metal ion 
complexation reagents.
[4]
 However, little is known about the 2,5-disubstituted 1,3,4-selenadiazoles.
[5]
 
Several methods have been reported for their preparation, which include a ring-closure reaction of 
selenobenzamides with hydrazine hydrate,
[6]
 reacting dimethylformamide azine with hydrogen 
selenide,
[7]
 treatment of 1,2-diacetylhydrazine with phosphorus pentaselenide,
[8]
 reaction of 
isoselenocyanates with selenosemicarbazides
[9]




 However, the examples of these compounds in the literature are limited due to 
either lack of starting materials or very low yield. 
    2,4-Bis(phenyl)-1,3-diselenadiphosphetane 2,4-diselenide [PhP(Se)(µ-Se)]2, known as Woollins’ 
reagent (WR), is the selenium counterpart of the well-known Lawesson’s reagent [p-MeOC6H4P(S)(µ-
S)]2 (LR). LR has been used extensively for various thionation reactions.
[11] 
Compared with other 
selenation reagents WR has broad utility and is useful in the synthesis of a wide range of selenium-
containing compounds. These compounds include large P/Se molecular aggregates or metal complexes 
by nucleophilic ring-opening reactions with alkali-metal thiolates,
[12] 
selenoamides and selenoaldehydes 
by simple oxygen/selenium exchange or reaction with ArCN followed by hydrolysis and a wide variety 
of P-Se heterocycles.
[13]
 Here, we report the synthesis and characterization of a series of novel 2,5-
disubstituted 1,3,4-selenadiazoles from the selenation of the corresponding 1,2-diacylhydrazine with 
WR. To the best of our knowledge, this is the first report of the systematic synthesis of 2,5-disubstituted 
1,3,4-selenadiazoles.  Furthermore, six examples, representing the first examples of this class have been 
structurally characterised. 
 
Results and Discussion 
Preparation of 1,2-diacylhydrazines 1a-t was very straightforward using a modification of the 
literature method.
[14]
 Reaction between hydrazides and carbonyl chlorides in the presence of sodium 
carbonate leads to the corresponding 1a-t in good to excellent yields (57-90%, Scheme 1 and Table 1). 
Even though most of the 1,2-diacylhydrazines had been previously synthesized; our modification of the 
literature preparation improved the yield and synthetic efficiency of their preparation. 1,2-




C NMR and MS data. The Infrared 
spectrum of these compounds show a strong absorption in the region of 1599-1637 cm
-1
 and the 
13
C 
NMR spectra display a characteristic peak in the region of 139.0-171.1 ppm, both are assignable to 
characteristic carbonyl groups, confirming the formation of 1,2-diacylhydrazines. There is also a 
characteristic 
1
H NMR resonance from the NHNH group in the region of 9.80-10.69 ppm. Finally, the 





Scheme 1. Synthesis of 1,2-diacylhydrazines 1a-t and 2,5-disubstituted 1,3,4-selenadiazoles 2a-t 
 
2,5-Disubstituted 1,3,4-thiadiazoles, the sulfur counterpart of 2,5-disubstituted 1,3,4-selenadiazoles, 











 and anti-inflammatory drugs, along with activity as pesticides and fungicides,
[17,19]
 as well 
as other applications.
[4a-c,20]
 The most popular method for the synthesis of this class of compounds 
involves the cyclization and dehydration of thiohydrazides or other substrates with S-C-N-N-C-S 
moiety.
[4a,15,16]
 This is typically done via thionation of 1,2-diacylhydrazines with Lawesson’s reagent, 
followed by spontaneous cyclization and dehydrosulfurization.
[14c]
 Herein, we adopted a similar 
approach, that is, reacting 1,2-diacylhydrazines, 1a-t, with WR to afford a series of  2,5-disubstituted 
1,3,4-selenadiazoles, 2a-t, in moderate to excellent yield (51-99%, Scheme 1 and Table 1). It should be 




 = Aryl) 
is very fast and high yield (75-99%), while with the 1,2-diacylhydrazines bearing one aryl group and one 
pyridine group (R
1
 = Aryl; R
2
 = Pyr) is slow with relatively low yield (51 and 58% for compounds 2b 
and 2c, respectively), This is most likely due to the presence of the electron-withdrawing  pyridine group. 

















 1a-t  Yield (%) 2a-t Yield (%) 
C6H5 C6H5 1a 61 2a 98 
4-BrC6H4 4-BrC6H4 1b 65 2b 75 
C6H5 Pyridin-3-yl 1c 77 2c 51 
4-MeOC6H4 Pyridin-3-yl 1d 82 2d 58 
C6H5 4-MeC6H4 1e 63 2e 90 
C6H5 4-ClC6H4 1f 67 2f 97 
C6H5 4-BrC6H4 1g 69 2g 95 
C6H5 4-FC6H4 1h 81 2h 91 
C6H5 Thiophen-2-yl 1i 70 2i 97 
C6H5 C2H5O 1j 90 2j 99 
C6H5 Furan-2-yl 1k 81 2k 82 
4-MeC6H4 Furan-2-yl 1l 65 2l 90 
4-BrC6H4 Furan-2-yl 1m 63 2m 96 
4-MeOC6H4 4-MeC6H4 1n 69 2n 90 
4-MeOC6H4 C6H5 1p 77 2p 86 
4-MeC6H4 4-ClC6H4 1r 68 2r 83 
4-MeC6H4 4-FC6H4 1s 57 2s 79 
4-MeC6H4 4-BrC6H4 1t 81 2t 75 
 






Se NMR, IR spectroscopy 
and mass spectrometry. The elemental analyses for all of these new compounds were satisfactory. All of 








 in their mass 
spectra. The ν(C=N) vibrations are observed in the range of 1418-1495 cm-1, comparable with related 
hetercycles.
[21]
 The absence of  ν (1599-1637 cm
-1
 for C=O) and the presence of the typical 
13
C NMR 
signals in the range of 133.1-174.9 ppm for C=N double bond and 
77
Se NMR signals in the range of 
683.01-714.61 ppm indicate the formation of the five-membered ring systems, 2a-t.  
Surprisingly, to date, there have been no crystal structures of 1,3,4-selenadiazole yet reported. Here 
we report the structures of six examples 2b, 2h, 2k, 2m, 2p and 2s (Figure 1). Colourless block crystals 
of these compounds were obtained for X-ray analysis via slow evaporation of a dichloromethane solution 
into hexane. Details of the selected inter-atomic distances and angles are given in Table 2. Unfortunately, 
the data for 2g could not be well-refined though the structure is closely similar to the other six described 
here.
[22]
 The overall molecular structures of these compounds are very similar in geometry. The C2N2Se 
rings are approximately co-planar with the two aromatic substituents. This can be readily illustrated 
 5 
through a comparison of the torsion angles to the substituents which are all close to 180˚ [range 
176.1(7)-180.0(8)˚]. The C-Se bond lengths for all six compounds (ca. 1.87-1.89 Å) are similar to that of 
2,5-diarylselenophenes (ca. 1.86-1.89 Å).
[23]
 The distances in 2 are slightly shorter than those found in 
related structures containing single C-Se bonds (ca. 1.92-1.94 Å),
[24] 
indicating that some slight 
delocalisation in 2. However, the C-Se-C angles ranging between 81.9(2)-82.7(2)˚ in 2b, 2h, 2k, 2m, 2p 




























Table 2. Selected interatomic distances (Ǻ) and angles (˚) for 2b, 2h, 2k, 2m, 2p and 2s 
 2b 2h 2k 2m 2p 2s 
Se(1)-C(1)  1.885(10) 1.891(7) 1.861(5) 1.869(9) 1.880(3) 1.902(5) 
Se(1)-C(2)  1.884(10) 1.884(7) 1.887(5) 1.894(8) 1.877(3) 1.890(5) 
C(2)-N(2)  1.295(13) 1.296(9) 1.302(7) 1.299(12) 1.298(4) 1.301(6) 
N(2)-N(1)  1.381(12) 1.363(8) 1.374(7) 1.380(10) 1.373(4) 1.379(6) 
C(1)-N(1)  1.276(12) 1.307(9) 1.302(7) 1.295(12) 1.297(4) 1.294(6) 
       
C(1)-Se(1)-C(2)  81.9(4) 82.0(3) 81.9(2) 82.2(4) 82.22(15) 82.7(2) 
Se(1)-C(2)-N(2)  113.9(7) 114.7(5) 113.7(4) 112.9(6) 113.8(3) 113.5(4) 
C(2)-N(2)-N(1)  114.5(8) 114.1(6) 115.1(4) 115.8(8) 115.1(3) 114.7(4) 
N(2)-N(1)-C(1)  115.6(8) 116.5(6) 114.1(5) 114.0(8) 115.0(3) 116.8(4) 
N(1)-C(1)-Se(1)  114.0(8) 112.6(5) 115.2(4) 115.0(7) 113.9(3) 112.2(4) 
 
Conclusions 
    In summary, a highly efficient route for the preparation of a wide variety of 1,2-diacylhydrazines has 
been developed. The selenation of 1,2-diacylhydrazines using Woollins’ reagent, 2,4-bis(phenyl)-1,3-
diselenadiphosphetane-2,4-diselenide, provides a general and systemic approach to 2,5-disubstituted 
1,3,4-selenadiazoles. This method allows 2,5-disubstituted 1,3,4-selenadiazoles to be easily available for 
further investigations into their chemistry and biological properties. 
 
Experimental Section 
Unless otherwise stated, all reactions were carried out under on oxygen free nitrogen atmosphere using 
pre-dried solvents and standard Schlenk techniques, subsequent chromatographic and work up 




H (270 MHz), 
13








H} (51.4 MHz referenced to external 
Me2Se) NMR spectra were recorded at 25 
º
C (unless stated otherwise) on a JEOL GSX 270. IR spectra 
were recorded as KBr pellets in the range of 4000-250 cm
-1
 on a Perkin-Elmer 2000 FTIR/Raman 
spectrometer. Microanalysis was performed by the University of St-Andrews microanalysis service. 
Mass spectrometry was performed by the University of St Andrews Mass Spectrometry Service. X-ray 
crystal data as Table 3 for compounds 2b, 2g, 2h, 2k, 2m, 2p and 2s was collected at 93 K by using a 
Rigaku MM007 High brilliance RA generator/confocal optics and Mercury CCD system. Intensities 
were corrected for Lorentz-polarisation and for absorption. The structures were solved by direct 
methods. Hydrogen atoms bound to carbon were idealised. Structural refinements were obtained with 
 8 
full-matrix least-squares based on F
2
 by using the SHELXTL
 
CDC-contain the supplementary 
crystallographic data for this paper. These data for compounds 2b, 2h, 2k, 2m, 2p and 2s can be 
obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html  CCDC 711573-711578 or from 
the Cambridge Crystallographic Data centre, 12 Union Road, Cambridge CB2 1EZ, UK; Fax (+44) 
1223-336-033; E-mail: deposit@ccdc.cam.ac.uk. 
 
Table 3. Details of the X-ray data collections and refinements for 2b, 2h, 2k, 2m, 2p and 2s 
 2b 2h 2k 2m 2p 2s 
Formula C14H8Br2N2Se C14H9FN2Se C12H8N2OSe C12H7BrN2OSe C15H12N2OSe C15H11FN2Se 
M 443.00 303.19 275.16 354.07 315.23 317.22 
Crystal system Monoclinic Monoclinic Orthorhombic Monoclinic Orthorhombic Monoclinic 
Space group P21/c P21/c P212121 P21/c Pbca P21/c 
a/Å 15.421(6) 13.160(6) 7.217(3) 6.112(3) 14.222(6) 14.888(8) 
b/Å 14.353(5) 5.489(3) 13.857(5) 21.886(9) 6.056(3) 14.385(7) 
c/Å 6.121(2) 16.177(8) 10.474(3) 8.871(4) 29.774(15) 6.002(3) 
β 101.091(10) 99.108(12) 90 103.712(10) 90 97.699(13) 
U/A3 1329.4(8) 1153.8(10) 1047.4(6) 1152.8(9) 2564(2) 1273.9(11) 
Z 4 4 4 4 8 4 





























    Rint 0.120 0.103 0.101 0.217 0.049 0.161 













0.273 0.252 0.114 0.308 0.088 0.227 
 
 
General procedure for synthesis of 1,2-diacylhydrazines (1a-t) A suspension of carbonyl hydrazide 
(10.0 mmol) and anhydrous sodium carbonate (1.02 g, 10.0 mmol) in dry tetrahydrofuran (60 ml) and 
water (60 ml) was added to a stirring solution of the corresponding carbonyl chloride (11.0 mmol) in 30 
ml of tetrahydrofuran at 0˚C. The mixture was stirred at 0˚C for 1 h, and at room temperature for 4 h. A 
massive precipitation was observed. The product was harvested by filtration and washed three times with 
tetrahydrofuran and ethyl ether, then finally dried in vacuum.  
 
N’-Benzoylbenzohydrazide (1a). A white solid (61%, 1.45 g); m.p. 236-238˚C. Selected IR (KBr, cm-1): 
3201(s), 3001(s), 1670(m), 1633(vs), 1579(s), 1537(s), 1487(s), 1287(s), 687(m). 
1
H NMR (DMSO-d6, 
 9 
), 10.53 (s, 2H, NH), 7.94 (m, 4H, H2, H6 ArH), 7.55 (m, 6H, H3, H4, H5 ArH) ppm. 13C NMR 




4-Bromo-N’-(4-chlorobenzoyl)benzohydrazide (1b). A white solid (65%, 2.30 g); m.p. 302-303˚C. 
Selected IR (KBr, cm
-1
): 3187(s), 3017(w), 1601(vs), 1561(s), 1461(s), 1264(m), 1090(m), 1010(m), 
848(m), 742(m), 659(m). 
1
H NMR (DMSO-d6, ),  10.66 (s, 2H, NH), 7.95 (d, J(H,H) = 8.5 Hz, 2H, 
ArH), 7.87 (d, J(H,H) = 8.5 Hz, 2H, ArH), 7.75 (d, J(H,H) = 8.5 Hz, 2H, ArH), 7.62 (d, J(H,H) = 8.5 Hz, 
2H, ArH) ppm. 
13
C NMR (DMSO-d6, ), 165.5 (C=O), 165.4 (C=O), 137.4, 132.2, 132.1, 131.8, 130.1, 
130.0, 129.3, 126.3 ppm. MS (ES
+









N’-Benzoylnicotinohydrazide (1c). A white solid (77%, 1.85 g); m.p. 232-234˚C. Selected IR (KBr, 
cm
-1
): 3201(m), 3003(m), 1631(s), 1537(s), 1295(s), 874(m), 698(s). 
1
H NMR (DMSO-d6, ), 10.69 (s, 
2H, NH), 9.09 (s, 1H, PyH), 8.80 (d, 1H, PyH), 8.29 (d, 1H, PyH), 7.94 (m, 2H, ArH), 7.57 (m, 4H, PyH 
and ArH) ppm. 
13
C NMR (DMSO-d6, ),  166.3 (C=O), 165.0 (C=O), 153.1, 149.0, 135.8, 133.0, 132.5, 




N’-(4-Methoxybenzoyl)nicotinohydrazide (1d). A white solid (82%, 2.21 g); m.p. 126-128˚C. Selected 
IR (KBr, cm
-1
): 3203(m), 3003(m), 1632(s), 1605(s), 1503(s), 1258(s), 1175(m), 1026(m), 846(w), 
704(w). 
1
H NMR (DMSO-d6, ), 10.66 (s, 2H, NH), 9.10 (s, 1H, PyH), 8.79 (d, 1H, PyH), 8.30 (d, 1H, 
PyH), 7.93 (m, 2H, ArH), 7.58 (m, 1H, PyH), 7.07 (m, 2H, ArH), 3.84 (s, 3H, OCH3) ppm. 
13
C NMR 
(DMSO-d6, ),  165.9 (C=O), 165.1 (C=O), 153.1, 149.0, 135.8, 129.9, 128.9, 125.1, 124.3, 114.4, 114.0, 




N’-Benzoyl-4-methylbenzohydrazide (1e). A white solid (63%, 1.58 g); m.p. 219-221˚C. Selected IR 
(KBr, cm
-1
): 3202(s), 3007(s), 1631(vs), 1578(m), 1539(s), 1489(m), 1284(s), 691(m). 
1
H NMR 
(DMSO-d6, ), 10.45 (s, 2H, NH), 7.93 (d, J(H,H) = 7.7 Hz, 2H, ArH), 7.84 (d, J(H,H) = 7.4 Hz, 2H, 
ArH), 7.55 (m, 3H, ArH), 7.32 (d, J(H,H) = 7.4 Hz, 2H, ArH), 2.38 (s, 3H, CH3) ppm. 
13
C NMR 
(DMSO-d6, ), 166.4 (C=O), 166.2 (C=O), 142.4, 133.3, 132.4, 130.4, 129.6, 129.1, 128.0, 21.6 ppm. 




N’-Benzoyl-4-chlorobenzohydrazide (1f). A white solid (67%, 1.96 g); m.p. 224-226˚C. Selected IR 
(KBr, cm
-1
): 3195(s), 3010(w), 2843(w), 1599(vs), 1564(s), 1498(m), 1461(s), 1266(m), 1089(m), 
1010(m), 849(m), 710(m), 687(m), 647(m), 454(m). 
1
H NMR (DMSO-d6, ),  10.60 (s, 2H, NH), 7.94 
(m, 5H, ArH), 7.55 (m, 4H, ArH) ppm. 
13
C NMR (DMSO-d6, ), 166.4 (C=O), 165.4 (C=O), 137.3, 
 10 
133.1, 132.5, 131.9, 130.0, 129.2, 129.1, 128.0 ppm. MS (ES
+









N’- Benzoyl-4-bromobenzohydrazide (1g). A white solid (69%, 2.18 g); m.p. 207-209˚C. Selected IR 
(KBr, cm
-1
): 3192(s), 3009(w), 1600(vs), 1576(s), 1561(s), 1461(s), 1264(s), 706(m). 
1
H NMR (DMSO-
d6, ), 10.58 (s, 2H, NH), 7.91 (m, 3H, ArH), 7.77 (m, 2H, ArH), 7.55 (m, 4H, ArH) ppm. 
13
C NMR 
(DMSO-d6, ), 166.4 (C=O), 165.6 (C=O), 133.0, 132.5, 132.2, 130.1, 129.9, 129.1, 128.0, 126.3 ppm. 




N’-Benzoyl-4-fluorobenzohydrazide (1h). A white solid (81%, 2.06 g); m.p. 228-230˚C. Selected IR 
(KBr, cm
-1
): 3209(s), 3011(s), 1674(s), 1635(vs), 1605(s), 1538(s), 1504(s), 1283(s), 1240(s), 1160(m), 
849(m), 688(m), 594(m), 541(m). 
1
H NMR (DMSO-d6, ),  10.57 (s, 2H, NH), 8.02 (m, 2H, ArH), 7.95 
(m, 2H, ArH), 7.56 (m, 3H, ArH), 7.38 (m, 2H, ArH) ppm. 
13
C NMR (DMSO-d6, ), 166.4 (C=O), 165.4 
(C=O), 163.0, 133.1, 132.5, 139.7, 129.1, 128.0, 116.3, 116.0 ppm. MS (ES
+









N’- Benzoylthiophen-2-carbohydrazide (1i). A white solid (70%, 1.72 g); m.p. 102-104˚C. Selected IR 
(KBr, cm
-1
): 3210(m), 3020(m), 1715(m), 1652(s), 1536(s), 1270(s), 709(m). 
1
H NMR (DMSO-d6, ), 
9.80 (s, 2H, NH), 9.81 (s, 2H, NH), 9.00 (m, 3H), 7.72 (m, 3H), 7.13 (m, 2H). 
13
C NMR (DMSO-d6, ), 




Ethyl 2-benzoylhydrazinecarboxylate (1j). A white paste (90%, 1.85 g); Selected IR (KBr, cm
-1
): 
3208(m), 3021(m), 1711(s), 1650(s), 1530(m), 1326(m), 1267(s), 707(s). 
1
H NMR (DMSO-d6, ), 8.81 
(s, 2H, NH), 8.10 (m, 2H, ArH), 7.80 (m, 1H, ArH), 7.48 (m, 2H, ArH), 4.14 (q, J(H,H) = 7.2 Hz, 2H, 
OCH2), 1.23 (t, J(H,H) = 7.2 Hz, 3H, CH3) ppm. 
13
C NMR (DMSO-d6, ),  171.1 (C=O), 167.3 (C=O), 





N’-Benzoylfuran-2-carbohydrazide (1k). A white solid (81%, 1.85 g); m.p. 208-210˚C. Selected IR 
(KBr, cm
-1
): 3198(s), 1672(m), 1634(vs), 1592(m), 1580(m), 1525(m), 1471(m), 1291(s), 1221(m), 
1159(m), 1010(m), 846(m), 754(m), 703(m), 689(m), 594(m), 540(m). 
1
H NMR (DMSO-d6, ),  10.46 (s, 
2H, NH), 7.95 (m, 3H, ArH), 7.55 (m, 3H, ArH&FurH), 7.28 (d, 1H, FurH), 6.69 (t, 1H, FurH) ppm. 
13
C 
NMR (DMSO-d6, ), 166.4 (C=O), 157.9 (C=O), 146.9, 146.4, 133.0, 132.5, 129.1, 128.0, 115.2, 112.5 
ppm. MS (ES
+









N’-(4-Methylbenzoyl)furan)-2-carbohydrazide (1l). A white solid (65%, 1.57 g) ; m.p. 225-227˚C. 
Selected IR (KBr, cm
-1
): 3173(m), 3011(m), 1673(m), 1631(vs), 1592(m), 1527(m), 1504(m), 1471(m), 
1286, 1217(m), 1186(m), 1120(m), 1020(m), 851(m), 746(s), 595(s), 540(m). 
1
H NMR (DMSO-d6, ),  
10.37 (s, 2H, NH), 7.91 (d, 1H, FurH), 7.81 (d, J(H,H) = 6.6 Hz, 2H, ArH), 7.31 (d, J(H,H) = 6.6 Hz, 2H, 
ArH), 7.26 (d, 1H, FurH), 6.68 (m, 1H, FurH), 2.37 (s, 3H, CH3) ppm. 
13
C NMR (DMSO-d6, ), 166.3 







N’-(4-Bromobenzoyl)furan-2-carbohydrazide (1m). A white solid (63%, 1.95 g) ; m.p. 191-193˚C. 
Selected IR (KBr, cm
-1
): 3167(w), 3004(w), 1637(vs), 1592(s), 1520(m), 1483(m), 1289(m), 1010(m), 
840(m), 747(m), 594(m). 
1
H NMR (DMSO-d6, ),  10.57 (s, 2H, NH), 7.94 (d, J(H,H) = 10.2 Hz, 1H, 
FurH), 7.85 (d, J(H,H) = 8.2 Hz, 2H, ArH), 7.74 (d, J(H,H) = 8.2 Hz, 2H, ArH), 7.27 (d, J(H,H) = 10.2 
Hz, 1H, FurH), 6.69 (m, 1H, FurH) ppm. 
13
C NMR (DMSO-d6, ), 165.5 (C=O), 157.9 (C=O), 148.4, 
146.4, 132.5, 132.2, 130.1, 126.3, 115.3, 112.5 ppm. MS (ES
+









4-Methoxy-N’-(4-methylbenzoyl)benzohydrazide (1n). A white solid (69%, 1.94 g); m.p. 214-216˚C. 
Selected IR (KBr, cm
-1
): 3214(s), 3010(w), 2844(w), 1599(vs), 1561(m), 1512(m), 1469(m), 1440(m), 
1255(s), 1177(m), 1028(m), 840(m), 743(m), 598(m). (
1
H NMR (DMSO-d6, ),  10.35 (s, 2H, NH), 7.92 
(d, J(H,H) = 8.5 Hz, 2H, ArH), 7.83 (d, J(H,H) = 8.5 Hz, 2H, ArH), 7.31 (d, J(H,H) = 8.5 Hz, 2H, ArH), 
7.05 (d, J(H,H) = 8.5 Hz, 2H, ArH), 3.85 (s, 3H, OCH3), 2.37 (s, 3H, CH3) ppm. 
13
C NMR (DMSO-d6, 
), 166.4 (C=O), 165.9 (C=O), 162.6, 142.4, 130.4, 129.9, 129.6, 128.0, 125.3, 114.3, 56.0, 21.6 ppm. 
MS (ES
+




N’-Benzoyl-4-methoxybenzohydrazide (1p). A white solid (77%, 2.07 g); m.p. 188-190˚C. Selected IR 
(KBr, cm
-1
): 3206(s), 3005(s), 1632(s), 1607(s), 1542(m), 1505(s), 1260(s), 1175(m), 1031(m), 842(m), 
691(m). 
1
H NMR (DMSO-d6, ), 10.42 (s, 2H, NH), 7.92 (m, 4H, ArH), 7.55 (m, 3H, ArH), 7.07 (m, 2H, 
ArH), 3.41 (s, 3H, OCH3) ppm. 
13
C NMR (DMSO-d6, ), 166.5 (C=O), 165.9 (C=O), 133.3, 132.4, 




4-Chloro-N’-(4-methylbenzoyl)benzohydrazide (1r). A white solid (68%, 1.95 g); m.p. 255-256˚C. 
Selected IR (KBr, cm
-1
): 3193(s), 3014(w), 1599(vs), 1563(s), 1511(m), 1463(s), 1267(m), 1225(m), 
1090(m), 1012(m), 850(m), 741(m), 663(m), 603(m), 462(m). 
1
H NMR (DMSO-d6, ),  10.53 (s, 2H, 
NH), 7.94 (d, J(H,H) = 7.7 Hz, 2H, ArH), 7.74 (d, J(H,H) = 7.2 Hz, 2H, ArH), 7.61 (d, J(H,H) = 7.2 Hz, 
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2H, ArH), 7.33 (d, J(H,H) = 7.7 Hz, 2H, ArH), 2.38 (s, 3H, CH3) ppm. 
13
C NMR (DMSO-d6, ), 166.3 











4-Fluoro-N’-(4-methylbenzoyl)benzohydrazide (1s). A white solid (57%, 1.55 g); m.p. 224-225˚C. 
Selected IR (KBr, cm
-1
): 3202(m), 3013(w), 1605(vs), 1584(s), 1511(m), 1461(s), 1267(m), 1225(m), 
1155(m), 851(m), 742(m), 661(m), 600(m). 
1
H NMR (DMSO-d6, ),  10.49 (s, 2H, NH), 8.01 (d, J(H,H) 
= 6.3 Hz, 2H, ArH), 7.83 (d, J(H,H) = 6.3 Hz, 2H, ArH), 7.34 (m, 4H, ArH), 2.37 (s, 3H, CH3) ppm. 
13
C 
NMR (DMSO-d6, ), 166.3 (C=O), 165.4 (C=O), 162.9, 142.5, 130.8, 130.7, 130.3, 129.6, 128.1, 116.3, 
115.9, 21.6 ppm. MS (ES
+






4-Bromo-N’-(4-methoxybenzoyl)benzohydrazide (1t). A white solid (81%, 2.80 g); m.p. 240-242˚C. 
Selected IR (KBr, cm
-1
): 3209(m), 3009(w), 1600(vs), 1560(m), 1467(s), 1255(s), 1178(m), 1031(m), 
847(m), 744(m), 609(m). 
1
H NMR (DMSO-d6, ),  10.54 (s, 2H, NH), 7.90 (m, 4H, ArH), 7.76 (d, J(H,H) 
= 7.7 Hz, 2H, ArH), 7.05 (d, J(H,H) = 7.7 Hz, 2H, ArH), 3.83 (s, 3H, OCH3) ppm. 
13
C NMR (DMSO-d6, 





General procedure for the synthesis of 2,5-disubstituted 1,3,4-selenadiazoles (2a-t): A mixture of 
1,2-diacylhydrazines (1.0 mmol) and Woollins’ reagent (0.54g, 1.0 mmol) in 20 ml of dry toluene was 
refluxed for 7 h. The red suspension disappeared and a brown suspension was formed along with some 
grey elemental selenium. After cooling to room temperature the mixture was dried in vacuo to remove 
toluene. The residue was then dissolved in dichloromethane and purified by silica gel (1:5 ethyl acetate / 
dichloromethane as eluent) to give the corresponding target product. 
  
2,5-Diphenyl-1,3,4-selenadiazole (2a). A yellow solid (98%, 0.28 g); m.p. 116-118˚C. Selected IR (KBr, 
cm
-1
): 3424(s), 1438(m), 1149(s), 933(m), 691(s), 543(s). 
1
H NMR (CD2Cl2, ), 7.95 (m, 4H, ArH), 7.50 
(m, 6H, ArH) ppm. 
13
C NMR (CD2Cl2, ), 174.9 (C=N), 1431.2, 129.3, 128.7, 126.9 ppm. 
77
Se NMR 
(CD2Cl2, ), 687.13 ppm. MS (CI, m/z), 287 [M+H]
+
. C14H10N2Se (285.11): Calcd. C 58.98, H 3.54, N 
9.83; found C 59.30, H 3.85, N 9.79.  
 
2,5-Bis(4-bromophenyl)-1,3,4-selenadiazole (2b). ). A yellow solid (75%, 0.33 g); m.p. 210˚C (Dec.). 
Selected IR (KBr, cm
-1
): 3424(w), 2921(w), 1602(s), 1544(m), 1477(vs), 1397(m), 1266(w), 1090(s), 
1072(s), 1009(s), 838(s), 737(s), 520(m). 
1
H NMR (CD2Cl2, ), 8.06 (d, J(H,H) = 8.5 Hz, 2H, ArH), 7.98 
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(d, J(H,H) = 8.5 Hz, 2H, ArH), 7.67 (d, J(H,H) = 8.5 Hz, 2H, ArH), 7.51 (d, J(H,H) = 8.5 Hz, 2H, ArH) 
ppm. 
13
C NMR (CD2Cl2, ), 164.1 (C=N), 151.7 (C=N), 138.3, 132.6, 130.1, 129.9, 129.6, 128.4, 128.3, 
126.7, 122.7 ppm. 
77
Se NMR (CD2Cl2, ), 690.60 ppm. MS (CI, m/z), 443 [M+H]
+
. C14H8Br2N2Se 
(442.91): Calcd. C 37.96, H 1.82, N 6.32; found C 37.66, H 1.91; N 6.08. 
 
2-Phenyl-5-(pyridine-3-yl)-1,3,4-selenadiazole  (2c).  A greenish yellow solid (51%, 0.15 g); m.p. 90-
92˚C. Selected IR (KBr, cm-1): 3424(s), 1454(m), 1435(m), 1127(m), 1055(m), 761(m), 690(s), 532(s). 
1
H NMR (CD2Cl2, ), 8.38 (s, 1H, PyH), 8.13 (d, 1H, PyH), 7.93 (m, 3H, PyH & ArH), 7.57 (m, 4H, 
ArH) ppm. 
13
C NMR (CD2Cl2, ), 149.5 (C=N), 147.6 (C=N), 137.3, 131.6, 129.4, 128.9, 127.0, 124.9 
ppm. 
77
Se NMR (CD2Cl2, ), 698.88 ppm. MS (CI, m/z), 287 [M+H]
+
. C13H9N3Se (286.10): Calcd. C 
54.56, H 3.17, N 14.68; found C 54.10, H 3.61, N 14.57. 
 
2-(4-Methoxyphenyl)-5-(pyridine-3-yl)-1,3,4-selenadiazole  (2d). A yellow solid (58%, 0.18 g); m.p. 
98-100˚C. Selected IR (KBr, cm-1): 3425(m), 3049(m), 1454(m), 1434(s), 1140(m), 1081(m), 958(m), 
761(m), 690(s), 534(s). 
1
H NMR (CD2Cl2, ), 9.54 (s, 1H, PyH), 9.01 (d, 1H, PyH), 8.88 (d, 1H, PyH), 
8.01 (m, 3H, PyH & ArH), 7.47 (m, 4H, PyH & ArH), 3.86 (s, 3H, OCH3) ppm. 
13
C NMR (CD2Cl2, ), 
144.0 (C=N), 142.6 (C=N), 132.0, 129.4, 129.0, 128.4, 128.2, 127.9, 127.2, 55.8 ppm. 
77
Se NMR 
(CD2Cl2, ), 714.61 ppm. MS (CI, m/z), 318 [M+H]
+
. C14H12N3OSe (317.14): Calcd. C 53.18, H 3.51, N 
13.29; found C 53.51, H 3.61, N 13.57. 
 
2-Phenyl-5-p-tolyl-1,3,4-selenadiazole (2e). A yellow solid (90%, 0.27 g); m.p. 102-104˚C. Selected IR 
(KBr, cm
-1
): 2918(w), 1607(m), 1546(m), 1494(m), 1441(s), 1258(m), 1061(s), 962(m), 817(s), 757(m), 
685(s), 578(m). 
1
H NMR (CD2Cl2, ), 8.12 (d, J(H,H) = 7.2 Hz, 2H, ArH), 7.83 (d, J(H,H) = 7.9 Hz, 2H, 
ArH), 7.49 (m, 3H, ArH), 7.27 (d, J(H,H) = 7.9 Hz, 2H, ArH), 2.39 (s, 3H, CH3) ppm. 
13
C NMR 
(CD2Cl2, ), 164.8 (C=N), 164.4 (C=N), 141.9, 131.6, 131.0, 129.9, 129.2, 128.4, 126.8, 21.4 ppm. 
77
Se 
NMR (CD2Cl2, ), 683.01 ppm. MS (CI, m/z), 301 [M+H]
+
. C15H12N2Se (300.02): Calcd. C 60.21, H 
4.04, N 9.36; found C 60.31, H 4.29, N 9.51. 
 
2-(4-Chlorophenyl)-5-phenyl-1,3,4-selenadiazole (2f). A yellow solid (97%, 0.31 g); m.p. 198-199˚C. 
Selected IR (KBr, cm
-1
): 3424(w), 1590(m), 1494(m), 1440(vs), 1418(s), 1238(m), 1089(s), 1062(s), 
1010(m), 965(m), 845(m), 820(m), 762(s), 686(m), 661(m), 578(m). 
1
H NMR (CD2Cl2, ), 7.95 (m, 4H, 
ArH), 7.47 (m, 5H, ArH) ppm. 
13
C NMR (CD2Cl2, ), 136.9 (C=N), 133.1 (C=N), 131.7, 131.3, 129.9, 
129.5, 129.3, 128.7 ppm. 
77
Se NMR (CD2Cl2, ), 688.61 ppm. MS (ESI
+
, m/z), 343 [M+Na]
+
. 
C14H9ClN2Se (319.56): Calcd. C 52.61, H 2.84, N 8.76; found C 52.56, H 2.49, N 8.49. 
 14 
 
2-(4-Bromophenyl)-5-phenyl-1,3,4-selenadiazole (2g). A greenish yellow solid (95%, 0.35 g); m.p. 90-
92˚C. Selected IR (KBr, cm-1): 3449(w), 1583(m), 1492(m), 1439(s), 1417(m), 1256(m), 1063(s), 824(s), 
760(s), 688(s), 577(m). 
1
H NMR (CD2Cl2, ), 7.94 (d, 2H, ArH), 7.83 (d, 2H, ArH), 7.62 (m, 2H, ArH), 
7.50 (d, 3H, ArH) ppm. 
13
C NMR (CD2Cl2, ), 164.8 (C=N), 164.0 (C=N), 132.5, 131.9, 131.3, 130.0, 
129.3, 128.7, 128.3, 126.9 ppm. 
77
Se NMR (CD2Cl2, ), 688.75 ppm. MS (CI, m/z), 365 [M+H]
+
. 
C14H9BrN2Se (364.01): Calcd. C 46.18, H 2.49, N 7.69; found C 46.96, H 2.28, N 7.78. 
 
2-(4-Fluorophenyl)-5-phenyl-1,3,4-selenadiazole (2h). A greenish yellow solid (91%, 0.28 g); m.p. 
102-104˚C. Selected IR (KBr, cm-1): 3427(w), 3063(w), 1606(m), 1550(m), 1495(vs), 1445(m), 1415(m), 
1234(s), 1152(m), 1072(m), 844(s), 734(s), 687(s), 616(m), 523(m). 
1
H NMR (CD2Cl2, ), 8.15 (d, 2H, 
ArH), 7.96 (d, 2H, ArH), 7.53 (m, 3H, ArH), 7.25 (m, 2H, ArH) ppm. 
13
C NMR (CD2Cl2, ), 166.3 
(C=N), 163.8 (C=N), 131.8, 131.2, 130.7, 129.2, 128.7, 126.8, 117.2, 116.2 ppm. 
77
Se NMR (CD2Cl2, ), 
686.62 ppm. MS (ESI
+
, m/z), 327 [M+Na]
+
. C14H9FN2Se (303.10): Calcd. C 55.46, H 2.99, N 9.24; 
found C 55.56, H 2.93, N 9.17. 
 
2-Phenyl-5-(thiophen-2-yl)-1,3,4-selenadiazole  (2i). A yellow oil (92%, 0.31 g). Selected IR (KBr, 
cm
-1
): 3430(w), 3060(w), 1608(m), 1499(s), 1447(m), 1420(m), 1240(s), 1076(m), 739(s), 690(s), 
618(m), 525(m). 
1
H NMR (CD2Cl2, ), 7.94 (m, 1H, thiophen-H), 7.75-7.37 (m, 3H, ArH), 7.03 (m, 2H, 
ArH), 6.24 (m, 1H, thiophen-H), 6.12 (m, 1H, thiophen-H) ppm. 
13
C NMR (CD2Cl2, ), 166.6 (C=N), 
164.0 (C=N), 131.3, 131.2, 130.8, 129.3, 128.7, 128.3, 127.6, 127.5, 127.1 ppm. 
77
Se NMR (CD2Cl2, ), 
688.24 ppm. MS (CI, m/z), 341 [M+H]
+
. C12H8N2Se2 (337.94): Calcd. C 42.63, H 2.39, N 8.28; found C 
42.90, H 2.48, N 8.08. 
 
2-Ethoxy-5-phenyl-1,3,4-selenadiazole  (2j). A yellow paste (99%, 0.25 g). Selected IR (KBr, cm
-1
): 
3056(w), 2926(w), 1757(s), 1719(s), 1690(m), 1438(m), 1369(m), 1307(m), 1281(s), 1232(s), 758(m), 
686(s), 543(m). 
1
H NMR (CD2Cl2, ), 8.14 (m, 2H, ArH), 7.54 (m, 3H, ArH), 4.17 (t, 2H, OCH2), 1.25 
(q, 3H, CH3) ppm. 
13
C NMR (CD2Cl2, ), 135.6 (C=N), 134.4 (C=N), 133.0, 132.4, 132.2, 131.3, 130.8, 
64.1, 13.8 ppm. 
77
Se NMR (CD2Cl2, ), 687.45 ppm. MS (CI, m/z), 255 [M+H]
+
. C10H10N2OSe (253.07): 
Calcd. C 47.44, H 3.98, N 11.07; found C 47.01, H 3.88, N 10.93. 
 
2-(Furan-2-yl)-5-phenyl-1,3,4-selenadiazole (2k). A yellow solid (82%, 0.23 g); m.p. 100-102˚C. 
Selected IR (KBr, cm
-1
): 3137(m), 1634(m), 1582(m), 1487(s), 1453(s), 1421(m), 1259(m), 1222(m), 
1058(m), 1018(s), 879(s), 763(vs), 750(vs), 689(vs), 658(s), 588(s), 557(m). 
1
H NMR (CD2Cl2, ), 7.94 
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(m, 2H, ArH), 7.64 (d, 1H, FurH), 7.47 (m, 3H, ArH), 7.17 (d, 1H, FurH), 6.61 (m, 1H, FurH) ppm. 
13
C 
NMR (CD2Cl2, ), 145.9 (C=N), 145.4 (C=N), 131.9, 131.2, 129.3, 128.7, 126.9, 114.0, 112.8, 112.2, 
110.9 ppm. 
77
Se NMR (CD2Cl2, ), 692.12 ppm. MS (ESI
+
, m/z), 299 [M+Na]
+
. C12H8N2OSe (275.08): 
Calcd. C 52.38, H 2.93, N 10.18; found C 52.34, H 2.81, N 10.27. 
 
2-(Furan-2-yl)-5-p-tolyl-1,3,4-selenadiazole (2l). A yellow solid (90%, 0.24 g); m.p. 98-100˚C. 
Selected IR (KBr, cm
-1
): 3449(w), 3104(w), 2896(w), 1607(m), 1492(m), 1443(s), 1261(m), 1061(m), 
1017(s), 880(m), 819(s), 754(s), 596(m), 558(m). 
1
H NMR (CD2Cl2, ), 7.79 (m, 3H), 7.26 (m, 3H), 6.61 
(m, 1H), 2.42 (s, 3H, CH3) ppm. 
13
C NMR (CD2Cl2, ), 174.1 (C=N), 163.0 (C=N), 145.8, 145.2, 141.9, 
129.9, 128.5, 112.7, 110.7, 21.3 ppm. 
77
Se NMR (CD2Cl2, ), 688.42 ppm. MS (ESI
+
, m/z), 313 
[M+Na]
+
. C13H10N2OSe (289.10): Calcd. C 57.15, H 3.69, N 10.25; found C 56.75, H 3.54, N 10.14. 
 
2-(4-Bromophenyl)-5-(furan-2-yl)-1,3,4-selenadiazole (2m). A yellow solid (96%, 0.34 g); m.p. 138-
140˚C. Selected IR (KBr, cm-1): 3449(m), 2920(w), 2848(w), 1586(m), 1489(s), 1445(s), 1391(m), 
1254(m), 1217(m), 1055(m), 1018(m), 879(m), 815(s), 743(s), 591(m), 554(m). 
1
H NMR (CD2Cl2, ), 
7.80 (d, 2H, ArH), 7.61 (d, 2H, ArH), 7.78 (d, 1H, FurH), 7.19 (d, 1H, FurH), 6.61 (m, 1H, FurH) ppm. 
13
C NMR (CD2Cl2, ), 172.7 (C=N), 163.8 (C=N), 146.1, 145.5, 132.5, 130.0, 128.4, 125.4, 112.9, 111.1 
ppm. 
77
Se NMR (CD2Cl2, ), 693.47 ppm. MS (CI, m/z), 355 [M+H]
+
. C12H7BrN2OSe (353.97): Calcd. 
C 40.71, H 1.99, N 7.91; found C 40.96, H 1.92, N 8.01. 
 
2-(4-Methoxyphenyl)-5-p-tolyl-1,3,4-selenadiazole (2n). A yellow solid (90%, 0.29 g); m.p. 178-180˚C. 
Selected IR (KBr, cm
-1
): 3450(w), 2961(w), 1603(s), 1513(m), 1452(s), 1407(m), 1307(m), 1256(vs), 
1177(m), 1065(m), 1034(m), 836(s), 817(s), 606(m), 578(m). 
1
H NMR (CD2Cl2, ), 7.85 (m, 4H, ArH), 
7.27 (d, J(H,H) = 7.7 Hz, 2H, ArH), 6.96 (d, J(H,H) = 7.7 Hz, 2H, ArH), 3.85 (s, 3H, OCH3), 2.39 (s, 3H, 
CH3) ppm. 
13
C NMR (CD2Cl2, ), 174.0 (C=N), 162.0 (C=N), 141.7, 130.5, 130.2, 129.9, 128.5, 126.0, 
114.5, 55.6, 21.3 ppm. 
77
Se NMR (CD2Cl2, ), 673.66 ppm. MS (ESI
+
, m/z), 353 [M+Na]
+
. 
C16H14N2OSe (329.17): Calcd. C 58.37, H 4.29, N 8.51; found C 58.51, H 3.86, N, 8.19. 
 
2-(4-Methoxyphenyl)-5-phenyl-1,3,4-selenadiazole (2p). A yellow solid (86%, 0.27 g); m.p. 130-
132˚C. Selected IR (KBr, cm-1): 2936(w), 2831(w), 1604(s), 1513(m), 1438(s), 1253(vs), 1178(m), 
1034(m), 763(m). 
1
H NMR (CD2Cl2, ), 7.91 (m, 4H, ArH), 7.48 (m, 3H, ArH), 6.99 (m, 2H, ArH), 3.85 
(s, 3H, OCH3) ppm. 
13
C NMR (CD2Cl2, ), 174.5 (C=N), 173.9 (C=N), 133.3, 131.0, 130.2, 129.2, 128.6, 
126.3, 125.9, 114.6, 55.6 ppm. 
77
Se NMR (CD2Cl2, ), 677.36 ppm. MS (CI, m/z), 317 [M+H]
+
. 
C15H12N2OSe (315.14): Calcd. C 57.15, H 3.04, N 8.89; found C 56.54, H 3.62, N 8.94.  
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2-(4-Chlorophenyl)-5-p-tolyl-1,3,4-selenadiazole (2r). A yellow solid (83%, 0.27 g); m.p. 184-186˚C. 
Selected IR (KBr, cm
-1
): 3453(w), 3074(w), 2914(w), 1601(m), 1588(m), 1441(s), 1431(s), 1396(m), 
1261(m), 1073(m), 817(vs), 577(m), 470(m). 
1
H NMR (CD2Cl2, ), 8.05 (m, 4H, ArH), 7.51 (d, J(H,H) 
= 6.9 Hz, 2H, ArH), 7.34 (d, J(H,H) = 6.9 Hz, 2H, ArH), 2.48 (s, 3H, CH3) ppm. 
13
C NMR (CD2Cl2, ), 
164.9 (C=N), 163.6 (C=N), 142.7, 137.7, 129.9, 129.5, 128.6, 128.1, 126.8, 122.8, 21.4 ppm. 
77
Se NMR 
(CD2Cl2, ), 684.21 ppm. MS (ESI, m/z), 357 [M+Na]
+
. C15H11ClN2Se (333.59): Calcd. C 53.99, H 3.32, 
N 8.40; found C 54.06, H 3.28, N 8.78. 
 
2-(4-Fluorophenyl)-5-p-tolyl-1,3,4-selenadiazole (2s). A greenish yellow solid (79%, 0.25 g); m.p. 
149-151˚C. Selected IR (KBr, cm-1): 3062(w), 2920(w), 1607(m), 1494(vs), 1228(s), 1158(m), 1069(m), 
1012(m), 963(m), 846(m), 818(m), 741(m), 638(m), 500(m). 
1
H NMR (CD2Cl2, ), 8.10 (m, 4H, ArH), 
7.27 (m, 4H, ArH), 2.61 (s, 3H, CH3) ppm. 
13
C NMR (CD2Cl2, ), 166.6 (C=N), 163.0 (C=N), 142.6, 
130.7, 129.9, 129.2, 128.6, 126.8, 116.6, 116.2, 21.4 ppm. 
77
Se NMR (CD2Cl2, ), 682.36 ppm. MS 
(ESI
+
, m/z), 341 [M+Na]
+
. C15H11FN2Se (317.13): Calcd. C 56.79, H 3.50, N 8.83; found C 56.66, H 
3.28, N 8.98. 
 
2-(4-Bromophenyl)-5-(4-methoxyphenyl)-1,3,4-selenadiazole (2t). A yellow solid (75%, 0.30 g); m.p. 
148-150˚C. Selected IR (KBr, cm-1): 2966(w), 2838(w), 1615(s), 1494(s), 1478(m), 1307(m), 1258(s), 
1126(m), 1076(m), 1029(m), 1009(m), 839(s), 742(s), 503(m). 
1
H NMR (CD2Cl2, ), 8.03 (m, 4H, ArH), 
7.68 (d, J(H,H) = 8.8 Hz, 2H, ArH), 7.04 (d, J(H,H) = 8.8 Hz, 2H, ArH), 3.87 (s, 3H, OCH3) ppm. 
13
C 
NMR (CD2Cl2, ), 166.2 (C=N), 163.5 (C=N), 132.4, 130.3, 128.6, 128.2, 126.0, 123.2, 116.3, 114.6, 
55.6 ppm. 
77
Se NMR (CD2Cl2, ), 678.61 ppm. MS (CI, m/z), 395 [M+H]
+
. C15H11BrN2OSe (394.04): 
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